Share Price and Basic Stock Data
Last Updated: February 10, 2026, 8:32 pm
| PEG Ratio | 3.48 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
CCL Products (India) Ltd, a prominent player in the Plantations – Tea & Coffee sector, reported a market capitalization of ₹12,922 Cr and a share price of ₹969. The company’s sales have shown a significant upward trajectory, rising from ₹1,462 Cr in March 2022 to ₹2,071 Cr in March 2023, and projected to reach ₹3,106 Cr by March 2025. This growth reflects a robust quarterly performance, with sales increasing from ₹507 Cr in September 2022 to ₹664 Cr in December 2023, and further to ₹727 Cr by March 2024. The sales momentum continued, reaching ₹1,127 Cr by September 2025. The operating profit margin (OPM) has fluctuated, registering 19% in March 2023, but declining to a projected 18% in March 2025. Overall, the consistent revenue growth positions CCL Products favorably in a competitive landscape, indicating strong demand for its products.
Profitability and Efficiency Metrics
CCL Products exhibited impressive profitability metrics, with a net profit of ₹338 Cr reported for the trailing twelve months (TTM). The net profit margin stood at 9.99% in March 2025, reflecting a steady performance compared to previous years. The return on equity (ROE) was recorded at 17.0%, while the return on capital employed (ROCE) stood at 13.1%. The interest coverage ratio (ICR) of 4.99x indicates that the company comfortably meets its interest obligations, showcasing operational efficiency. However, the operating profit margin (OPM) has experienced fluctuations, declining from 19% in March 2022 to a projected 18% in March 2025. The company also demonstrated a cash conversion cycle (CCC) of 246 days, which, while indicative of operational efficiency, suggests some room for improvement compared to sector averages. Overall, CCL Products’ profitability metrics reflect a solid performance, bolstered by efficient operational management.
Balance Sheet Strength and Financial Ratios
The balance sheet of CCL Products showcases a robust financial position, with total assets amounting to ₹4,241 Cr in March 2025. The company’s reserves have grown significantly, reaching ₹2,060 Cr, supporting its equity base. Total borrowings stood at ₹1,628 Cr, resulting in a total debt-to-equity ratio of 0.92, which is relatively low compared to industry norms. This indicates prudent financial management and a lower reliance on debt financing. The current ratio of 1.28 suggests that the company has sufficient liquidity to meet its short-term obligations. Additionally, the enterprise value (EV) of ₹9,123.03 Cr reflects a healthy valuation against its net operating revenue. The price-to-book value (P/BV) ratio of 3.77x indicates a premium valuation, suggesting investor confidence in the company’s growth prospects. Overall, CCL Products maintains a strong balance sheet with manageable debt levels, positioning it favorably for future expansions.
Shareholding Pattern and Investor Confidence
The shareholding pattern of CCL Products reveals a diverse ownership structure, with promoters holding 46.11% of the company, reflecting strong insider confidence. Foreign institutional investors (FIIs) accounted for 10.52%, while domestic institutional investors (DIIs) held 21.83% of the shares, indicating significant institutional interest in the company. The public shareholding stood at 21.29%, with the number of shareholders increasing to 55,690 as of September 2025. This growth in shareholder base reflects rising investor confidence in the company’s performance and strategic direction. The dividend payout ratio has been relatively conservative, recorded at 8.60% for March 2025, allowing the company to retain a substantial portion of earnings for reinvestment. The consistent presence of institutional investors and a growing shareholder base suggest a positive outlook for investor sentiment towards CCL Products.
Outlook, Risks, and Final Insight
CCL Products is well-positioned for continued growth, driven by its expanding revenue base and efficient operational management. However, the company faces certain risks, including potential fluctuations in raw material costs and market demand, which could impact profitability margins. Additionally, the high cash conversion cycle indicates challenges in inventory management that may affect liquidity. Despite these risks, the company’s strong balance sheet, healthy profit margins, and robust shareholder support provide a solid foundation for growth. Looking ahead, CCL Products could explore opportunities for expansion into new markets or product lines, leveraging its established brand strength. If the company can effectively manage its operational efficiencies and mitigate external risks, it is likely to enhance its competitive positioning in the industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Goodricke Group Ltd | 357 Cr. | 165 | 270/150 | 123 | 149 | 0.00 % | 3.22 % | 2.86 % | 10.0 |
| Diana Tea Company Ltd | 42.1 Cr. | 28.1 | 42.0/23.3 | 47.3 | 0.00 % | 1.40 % | 7.16 % | 5.00 | |
| Bengal Tea & Fabrics Ltd | 142 Cr. | 158 | 185/126 | 14.1 | 223 | 0.95 % | 5.22 % | 55.3 % | 10.0 |
| Bansisons Tea Industries Ltd | 10.0 Cr. | 15.9 | 15.9/5.60 | 9.42 | 0.00 % | 1.01 % | 1.01 % | 10.0 | |
| B&A Ltd | 123 Cr. | 398 | 639/350 | 13.2 | 528 | 0.00 % | 8.96 % | 6.02 % | 10.0 |
| Industry Average | 8,850.47 Cr | 397.73 | 66.83 | 265.00 | 0.43% | 7.88% | 16.74% | 7.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 535 | 520 | 655 | 608 | 664 | 727 | 773 | 738 | 758 | 836 | 1,056 | 1,127 | 1,051 |
| Expenses | 435 | 407 | 549 | 498 | 554 | 609 | 643 | 601 | 634 | 673 | 897 | 930 | 866 |
| Operating Profit | 101 | 113 | 106 | 110 | 111 | 118 | 130 | 137 | 124 | 163 | 159 | 197 | 185 |
| OPM % | 19% | 22% | 16% | 18% | 17% | 16% | 17% | 19% | 16% | 20% | 15% | 18% | 18% |
| Other Income | 0 | 2 | 0 | 1 | 1 | 4 | 1 | 1 | 3 | 4 | 2 | 1 | 3 |
| Interest | 11 | 11 | 15 | 18 | 23 | 21 | 21 | 27 | 31 | 34 | 34 | 33 | 32 |
| Depreciation | 19 | 10 | 22 | 23 | 22 | 31 | 23 | 24 | 25 | 27 | 34 | 39 | 39 |
| Profit before tax | 71 | 95 | 69 | 70 | 67 | 70 | 87 | 87 | 72 | 106 | 94 | 127 | 116 |
| Tax % | -4% | 10% | 13% | 13% | 5% | 7% | 18% | 15% | 12% | 4% | 23% | 21% | 14% |
| Net Profit | 73 | 85 | 61 | 61 | 63 | 65 | 71 | 74 | 63 | 102 | 72 | 101 | 100 |
| EPS in Rs | 5.49 | 6.41 | 4.56 | 4.57 | 4.76 | 4.88 | 5.35 | 5.54 | 4.72 | 7.63 | 5.43 | 7.55 | 7.51 |
Last Updated: February 6, 2026, 9:46 am
Below is a detailed analysis of the quarterly data for CCL Products (India) Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 1,051.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,127.00 Cr. (Sep 2025) to 1,051.00 Cr., marking a decrease of 76.00 Cr..
- For Expenses, as of Dec 2025, the value is 866.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 930.00 Cr. (Sep 2025) to 866.00 Cr., marking a decrease of 64.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 185.00 Cr.. The value appears to be declining and may need further review. It has decreased from 197.00 Cr. (Sep 2025) to 185.00 Cr., marking a decrease of 12.00 Cr..
- For OPM %, as of Dec 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 18.00%.
- For Other Income, as of Dec 2025, the value is 3.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Sep 2025) to 3.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Dec 2025, the value is 32.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 33.00 Cr. (Sep 2025) to 32.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Dec 2025, the value is 39.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 39.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 116.00 Cr.. The value appears to be declining and may need further review. It has decreased from 127.00 Cr. (Sep 2025) to 116.00 Cr., marking a decrease of 11.00 Cr..
- For Tax %, as of Dec 2025, the value is 14.00%. The value appears to be improving (decreasing) as expected. It has decreased from 21.00% (Sep 2025) to 14.00%, marking a decrease of 7.00%.
- For Net Profit, as of Dec 2025, the value is 100.00 Cr.. The value appears to be declining and may need further review. It has decreased from 101.00 Cr. (Sep 2025) to 100.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 7.51. The value appears to be declining and may need further review. It has decreased from 7.55 (Sep 2025) to 7.51, marking a decrease of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:31 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 717 | 881 | 932 | 976 | 1,138 | 1,081 | 1,139 | 1,242 | 1,462 | 2,071 | 2,654 | 3,106 | 3,777 |
| Expenses | 574 | 709 | 727 | 744 | 899 | 836 | 853 | 945 | 1,131 | 1,671 | 2,208 | 2,551 | 3,133 |
| Operating Profit | 143 | 171 | 205 | 232 | 239 | 245 | 286 | 298 | 331 | 400 | 445 | 555 | 644 |
| OPM % | 20% | 19% | 22% | 24% | 21% | 23% | 25% | 24% | 23% | 19% | 17% | 18% | 17% |
| Other Income | 3 | 3 | 1 | 1 | 5 | 3 | 4 | 3 | 4 | 3 | 6 | 8 | 10 |
| Interest | 17 | 14 | 11 | 11 | 8 | 8 | 18 | 17 | 16 | 34 | 78 | 113 | 131 |
| Depreciation | 29 | 27 | 28 | 33 | 34 | 32 | 47 | 49 | 57 | 64 | 98 | 98 | 124 |
| Profit before tax | 100 | 134 | 167 | 189 | 202 | 209 | 225 | 235 | 261 | 305 | 276 | 352 | 399 |
| Tax % | 35% | 30% | 27% | 29% | 27% | 26% | 26% | 22% | 22% | 7% | 9% | 12% | |
| Net Profit | 64 | 94 | 122 | 135 | 148 | 155 | 166 | 182 | 204 | 284 | 250 | 310 | 338 |
| EPS in Rs | 4.84 | 7.06 | 9.18 | 10.12 | 11.14 | 11.64 | 12.47 | 13.70 | 15.36 | 21.35 | 18.73 | 23.24 | 25.33 |
| Dividend Payout % | 25% | 21% | 27% | 25% | 22% | 30% | 40% | 29% | 33% | 21% | 24% | 22% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 46.88% | 29.79% | 10.66% | 9.63% | 4.73% | 7.10% | 9.64% | 12.09% | 39.22% | -11.97% | 24.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -17.09% | -19.13% | -1.03% | -4.90% | 2.37% | 2.54% | 2.45% | 27.13% | -51.19% | 35.97% |
CCL Products (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 22% |
| 3 Years: | 29% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 13% |
| 3 Years: | 15% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 29% |
| 3 Years: | 23% |
| 1 Year: | 11% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 18% |
| 3 Years: | 18% |
| Last Year: | 17% |
Last Updated: September 5, 2025, 1:40 am
Balance Sheet
Last Updated: December 4, 2025, 1:05 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 326 | 395 | 483 | 602 | 713 | 812 | 902 | 1,061 | 1,224 | 1,471 | 1,647 | 1,941 | 2,060 |
| Borrowings | 292 | 229 | 210 | 142 | 311 | 416 | 469 | 559 | 655 | 920 | 1,622 | 1,815 | 1,628 |
| Other Liabilities | 80 | 111 | 81 | 78 | 83 | 166 | 112 | 142 | 164 | 180 | 240 | 459 | 574 |
| Total Liabilities | 725 | 762 | 801 | 848 | 1,134 | 1,422 | 1,509 | 1,788 | 2,070 | 2,597 | 3,536 | 4,241 | 4,288 |
| Fixed Assets | 361 | 340 | 417 | 393 | 371 | 383 | 724 | 798 | 882 | 1,257 | 1,252 | 1,622 | 2,027 |
| CWIP | 39 | 53 | 0 | 0 | 226 | 424 | 100 | 149 | 160 | 54 | 501 | 450 | 18 |
| Investments | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 324 | 367 | 382 | 453 | 535 | 613 | 684 | 841 | 1,028 | 1,286 | 1,783 | 2,169 | 2,244 |
| Total Assets | 725 | 762 | 801 | 848 | 1,134 | 1,422 | 1,509 | 1,788 | 2,070 | 2,597 | 3,536 | 4,241 | 4,288 |
Below is a detailed analysis of the balance sheet data for CCL Products (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 27.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,060.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,941.00 Cr. (Mar 2025) to 2,060.00 Cr., marking an increase of 119.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,628.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,815.00 Cr. (Mar 2025) to 1,628.00 Cr., marking a decrease of 187.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 574.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 459.00 Cr. (Mar 2025) to 574.00 Cr., marking an increase of 115.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,288.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,241.00 Cr. (Mar 2025) to 4,288.00 Cr., marking an increase of 47.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,027.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,622.00 Cr. (Mar 2025) to 2,027.00 Cr., marking an increase of 405.00 Cr..
- For CWIP, as of Sep 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 450.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 432.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,244.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,169.00 Cr. (Mar 2025) to 2,244.00 Cr., marking an increase of 75.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,288.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,241.00 Cr. (Mar 2025) to 4,288.00 Cr., marking an increase of 47.00 Cr..
Notably, the Reserves (2,060.00 Cr.) exceed the Borrowings (1,628.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -149.00 | -58.00 | -5.00 | 90.00 | -72.00 | -171.00 | -183.00 | -261.00 | -324.00 | -520.00 | 444.00 | 554.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 54 | 47 | 50 | 61 | 58 | 79 | 86 | 88 | 80 | 78 | 68 | 81 |
| Inventory Days | 118 | 116 | 99 | 121 | 97 | 123 | 170 | 198 | 262 | 187 | 185 | 208 |
| Days Payable | 18 | 29 | 8 | 8 | 5 | 35 | 16 | 13 | 23 | 24 | 23 | 44 |
| Cash Conversion Cycle | 155 | 134 | 142 | 174 | 150 | 168 | 240 | 272 | 319 | 241 | 230 | 246 |
| Working Capital Days | 36 | 45 | 37 | 81 | 89 | 43 | 103 | 59 | 77 | 58 | 40 | 42 |
| ROCE % | 19% | 23% | 26% | 27% | 23% | 19% | 18% | 17% | 16% | 16% | 12% | 13% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Axis Small Cap Fund | 6,890,846 | 2.45 | 650.63 | 6,893,602 | 2026-01-24 13:24:22 | -0.04% |
| Franklin India Small Cap Fund | 3,010,279 | 2.15 | 284.23 | 3,260,279 | 2025-12-15 00:22:23 | -7.67% |
| Motilal Oswal Small Cap Fund | 2,521,084 | 4.08 | 238.04 | N/A | N/A | N/A |
| SBI MNC Fund | 2,400,000 | 3.89 | 226.61 | 2,410,387 | 2026-01-26 05:04:32 | -0.43% |
| HSBC Small Cap Fund | 2,071,654 | 1.22 | 195.61 | N/A | N/A | N/A |
| Parag Parikh ELSS Tax Saver Fund | 1,401,976 | 2.24 | 132.37 | N/A | N/A | N/A |
| HSBC Value Fund | 1,380,800 | 0.88 | 130.38 | N/A | N/A | N/A |
| Aditya Birla Sun Life Small Cap Fund | 1,078,825 | 2.06 | 101.86 | N/A | N/A | N/A |
| Canara Robeco ELSS Tax Saver Fund | 808,294 | 0.85 | 76.32 | 846,204 | 2026-01-24 05:07:04 | -4.48% |
| HSBC Multi Cap Fund | 598,000 | 1.06 | 56.46 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 23.31 | 18.80 | 20.21 | 15.36 | 13.70 |
| Diluted EPS (Rs.) | 23.26 | 18.76 | 20.21 | 15.36 | 13.70 |
| Cash EPS (Rs.) | 30.61 | 26.14 | 25.00 | 19.68 | 17.42 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 147.33 | 125.82 | 111.42 | 94.02 | 81.73 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 147.33 | 125.82 | 111.42 | 94.02 | 81.73 |
| Revenue From Operations / Share (Rs.) | 232.59 | 199.48 | 155.70 | 109.90 | 93.40 |
| PBDIT / Share (Rs.) | 42.20 | 33.95 | 30.30 | 25.19 | 22.64 |
| PBIT / Share (Rs.) | 34.83 | 26.61 | 25.51 | 20.87 | 18.92 |
| PBT / Share (Rs.) | 26.38 | 20.77 | 22.93 | 19.65 | 17.65 |
| Net Profit / Share (Rs.) | 23.24 | 18.80 | 20.21 | 15.36 | 13.70 |
| NP After MI And SOA / Share (Rs.) | 23.24 | 18.80 | 20.21 | 15.36 | 13.70 |
| PBDIT Margin (%) | 18.14 | 17.01 | 19.46 | 22.92 | 24.23 |
| PBIT Margin (%) | 14.97 | 13.33 | 16.38 | 18.99 | 20.26 |
| PBT Margin (%) | 11.34 | 10.40 | 14.72 | 17.87 | 18.89 |
| Net Profit Margin (%) | 9.99 | 9.42 | 12.98 | 13.97 | 14.66 |
| NP After MI And SOA Margin (%) | 9.99 | 9.42 | 12.98 | 13.97 | 14.66 |
| Return on Networth / Equity (%) | 15.77 | 14.94 | 18.14 | 16.33 | 16.76 |
| Return on Capital Employeed (%) | 17.85 | 15.67 | 19.27 | 19.28 | 19.07 |
| Return On Assets (%) | 7.31 | 7.07 | 10.35 | 9.87 | 10.19 |
| Long Term Debt / Equity (X) | 0.28 | 0.30 | 0.13 | 0.08 | 0.16 |
| Total Debt / Equity (X) | 0.92 | 0.96 | 0.61 | 0.44 | 0.43 |
| Asset Turnover Ratio (%) | 0.79 | 0.86 | 0.68 | 0.54 | 0.53 |
| Current Ratio (X) | 1.28 | 1.36 | 1.49 | 1.57 | 1.69 |
| Quick Ratio (X) | 0.63 | 0.74 | 0.79 | 0.74 | 1.01 |
| Inventory Turnover Ratio (X) | 3.37 | 2.38 | 1.57 | 1.35 | 1.35 |
| Dividend Payout Ratio (NP) (%) | 8.60 | 26.59 | 24.73 | 32.54 | 14.59 |
| Dividend Payout Ratio (CP) (%) | 6.53 | 19.12 | 19.99 | 25.40 | 11.48 |
| Earning Retention Ratio (%) | 91.40 | 73.41 | 75.27 | 67.46 | 85.41 |
| Cash Earning Retention Ratio (%) | 93.47 | 80.88 | 80.01 | 74.60 | 88.52 |
| Interest Coverage Ratio (X) | 4.99 | 5.81 | 11.72 | 20.49 | 17.76 |
| Interest Coverage Ratio (Post Tax) (X) | 3.75 | 4.22 | 8.82 | 13.49 | 11.75 |
| Enterprise Value (Cr.) | 9123.03 | 9248.47 | 8386.00 | 5873.65 | 3469.07 |
| EV / Net Operating Revenue (X) | 2.94 | 3.49 | 4.05 | 4.02 | 2.79 |
| EV / EBITDA (X) | 16.19 | 20.48 | 20.80 | 17.53 | 11.52 |
| MarketCap / Net Operating Revenue (X) | 2.39 | 2.94 | 3.65 | 3.67 | 2.51 |
| Retention Ratios (%) | 91.39 | 73.40 | 75.26 | 67.45 | 85.40 |
| Price / BV (X) | 3.77 | 4.66 | 5.10 | 4.29 | 2.86 |
| Price / Net Operating Revenue (X) | 2.39 | 2.94 | 3.65 | 3.67 | 2.51 |
| EarningsYield | 0.04 | 0.03 | 0.03 | 0.03 | 0.05 |
After reviewing the key financial ratios for CCL Products (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 23.31. This value is within the healthy range. It has increased from 18.80 (Mar 24) to 23.31, marking an increase of 4.51.
- For Diluted EPS (Rs.), as of Mar 25, the value is 23.26. This value is within the healthy range. It has increased from 18.76 (Mar 24) to 23.26, marking an increase of 4.50.
- For Cash EPS (Rs.), as of Mar 25, the value is 30.61. This value is within the healthy range. It has increased from 26.14 (Mar 24) to 30.61, marking an increase of 4.47.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 147.33. It has increased from 125.82 (Mar 24) to 147.33, marking an increase of 21.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 147.33. It has increased from 125.82 (Mar 24) to 147.33, marking an increase of 21.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 232.59. It has increased from 199.48 (Mar 24) to 232.59, marking an increase of 33.11.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 42.20. This value is within the healthy range. It has increased from 33.95 (Mar 24) to 42.20, marking an increase of 8.25.
- For PBIT / Share (Rs.), as of Mar 25, the value is 34.83. This value is within the healthy range. It has increased from 26.61 (Mar 24) to 34.83, marking an increase of 8.22.
- For PBT / Share (Rs.), as of Mar 25, the value is 26.38. This value is within the healthy range. It has increased from 20.77 (Mar 24) to 26.38, marking an increase of 5.61.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 23.24. This value is within the healthy range. It has increased from 18.80 (Mar 24) to 23.24, marking an increase of 4.44.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.24. This value is within the healthy range. It has increased from 18.80 (Mar 24) to 23.24, marking an increase of 4.44.
- For PBDIT Margin (%), as of Mar 25, the value is 18.14. This value is within the healthy range. It has increased from 17.01 (Mar 24) to 18.14, marking an increase of 1.13.
- For PBIT Margin (%), as of Mar 25, the value is 14.97. This value is within the healthy range. It has increased from 13.33 (Mar 24) to 14.97, marking an increase of 1.64.
- For PBT Margin (%), as of Mar 25, the value is 11.34. This value is within the healthy range. It has increased from 10.40 (Mar 24) to 11.34, marking an increase of 0.94.
- For Net Profit Margin (%), as of Mar 25, the value is 9.99. This value is within the healthy range. It has increased from 9.42 (Mar 24) to 9.99, marking an increase of 0.57.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 9.99. This value is within the healthy range. It has increased from 9.42 (Mar 24) to 9.99, marking an increase of 0.57.
- For Return on Networth / Equity (%), as of Mar 25, the value is 15.77. This value is within the healthy range. It has increased from 14.94 (Mar 24) to 15.77, marking an increase of 0.83.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.85. This value is within the healthy range. It has increased from 15.67 (Mar 24) to 17.85, marking an increase of 2.18.
- For Return On Assets (%), as of Mar 25, the value is 7.31. This value is within the healthy range. It has increased from 7.07 (Mar 24) to 7.31, marking an increase of 0.24.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.28. This value is within the healthy range. It has decreased from 0.30 (Mar 24) to 0.28, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.92. This value is within the healthy range. It has decreased from 0.96 (Mar 24) to 0.92, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.79. It has decreased from 0.86 (Mar 24) to 0.79, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.28. This value is below the healthy minimum of 1.5. It has decreased from 1.36 (Mar 24) to 1.28, marking a decrease of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has decreased from 0.74 (Mar 24) to 0.63, marking a decrease of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.37. This value is below the healthy minimum of 4. It has increased from 2.38 (Mar 24) to 3.37, marking an increase of 0.99.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.60. This value is below the healthy minimum of 20. It has decreased from 26.59 (Mar 24) to 8.60, marking a decrease of 17.99.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.53. This value is below the healthy minimum of 20. It has decreased from 19.12 (Mar 24) to 6.53, marking a decrease of 12.59.
- For Earning Retention Ratio (%), as of Mar 25, the value is 91.40. This value exceeds the healthy maximum of 70. It has increased from 73.41 (Mar 24) to 91.40, marking an increase of 17.99.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.47. This value exceeds the healthy maximum of 70. It has increased from 80.88 (Mar 24) to 93.47, marking an increase of 12.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 4.99. This value is within the healthy range. It has decreased from 5.81 (Mar 24) to 4.99, marking a decrease of 0.82.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.75. This value is within the healthy range. It has decreased from 4.22 (Mar 24) to 3.75, marking a decrease of 0.47.
- For Enterprise Value (Cr.), as of Mar 25, the value is 9,123.03. It has decreased from 9,248.47 (Mar 24) to 9,123.03, marking a decrease of 125.44.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.94. This value is within the healthy range. It has decreased from 3.49 (Mar 24) to 2.94, marking a decrease of 0.55.
- For EV / EBITDA (X), as of Mar 25, the value is 16.19. This value exceeds the healthy maximum of 15. It has decreased from 20.48 (Mar 24) to 16.19, marking a decrease of 4.29.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 2.94 (Mar 24) to 2.39, marking a decrease of 0.55.
- For Retention Ratios (%), as of Mar 25, the value is 91.39. This value exceeds the healthy maximum of 70. It has increased from 73.40 (Mar 24) to 91.39, marking an increase of 17.99.
- For Price / BV (X), as of Mar 25, the value is 3.77. This value exceeds the healthy maximum of 3. It has decreased from 4.66 (Mar 24) to 3.77, marking a decrease of 0.89.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.39. This value is within the healthy range. It has decreased from 2.94 (Mar 24) to 2.39, marking a decrease of 0.55.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CCL Products (India) Ltd:
- Net Profit Margin: 9.99%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.85% (Industry Average ROCE: 7.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.77% (Industry Average ROE: 16.74%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 36.6 (Industry average Stock P/E: 66.83)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.92
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 9.99%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plantations - Tea & Coffee | Duggirala, Guntur District Andhra Pradesh 522330 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Challa Rajendra Prasad | Executive Chairman |
| Mr. Challa Srishant | Managing Director |
| Mr. B Mohan Krishna | Executive Director |
| Ms. Challa Shantha Prasad | Non Executive Director |
| Mr. Satyavada Venkata Ramachandra Rao | Non Executive Director |
| Mr. K V Chowdary | Independent Director |
| Mr. Durga Prasad Kode | Independent Director |
| Mrs. Kulsoom Noor Saifullah | Independent Director |
| Dr. Krishnanand Lanka | Independent Director |
| Mr. Sudhakar Ambati | Independent Director |
FAQ
What is the intrinsic value of CCL Products (India) Ltd?
CCL Products (India) Ltd's intrinsic value (as of 11 February 2026) is ₹862.33 which is 16.36% lower the current market price of ₹1,031.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹13,760 Cr. market cap, FY2025-2026 high/low of ₹1,074/475, reserves of ₹2,060 Cr, and liabilities of ₹4,288 Cr.
What is the Market Cap of CCL Products (India) Ltd?
The Market Cap of CCL Products (India) Ltd is 13,760 Cr..
What is the current Stock Price of CCL Products (India) Ltd as on 11 February 2026?
The current stock price of CCL Products (India) Ltd as on 11 February 2026 is ₹1,031.
What is the High / Low of CCL Products (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of CCL Products (India) Ltd stocks is ₹1,074/475.
What is the Stock P/E of CCL Products (India) Ltd?
The Stock P/E of CCL Products (India) Ltd is 36.6.
What is the Book Value of CCL Products (India) Ltd?
The Book Value of CCL Products (India) Ltd is 156.
What is the Dividend Yield of CCL Products (India) Ltd?
The Dividend Yield of CCL Products (India) Ltd is 0.48 %.
What is the ROCE of CCL Products (India) Ltd?
The ROCE of CCL Products (India) Ltd is 13.1 %.
What is the ROE of CCL Products (India) Ltd?
The ROE of CCL Products (India) Ltd is 17.0 %.
What is the Face Value of CCL Products (India) Ltd?
The Face Value of CCL Products (India) Ltd is 2.00.